0000899243-20-017544.txt : 20200624 0000899243-20-017544.hdr.sgml : 20200624 20200624163032 ACCESSION NUMBER: 0000899243-20-017544 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wanstall Rick CENTRAL INDEX KEY: 0001771222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 20985811 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-23 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001771222 Wanstall Rick C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472 0 1 0 0 See Remarks Stock Option (right to buy) 1.20 2020-06-23 4 A 0 91000 0.00 A 2030-06-22 Common Stock 91000 91000 D This option was granted on June 23, 2020. The shares underlying the option are scheduled to vest in equal monthly installments over four years from June 23, 2020. Chief Financial Officer and Treasurer /s/ Richard Wanstall 2020-06-24